> GlaxoSmithKline ($GSK) and Apotex sued India-based Lupin over the latter's plans to sell copycat versions of the antidepressant Paxil in the U.S. Report
> Pharmacy benefits manager Express Scripts ($ESRX) agreed to pay $60 million to resolve federal and state claims that it participated in a kickback scheme to boost sales of the Novartis ($NVS) drug Exjade. Report
> GlaxoSmithKline landed in second place on a U.K. list of companies ranked by social media savvy. Report
> Sanofi ($SNY) inked a two-year deal to help train family doctors in the United Arab Emirates, in a variety of disease areas including cardiovascular and diabetes. Report
> The Centers for Medicare and Medicaid Services released a massive database on prescribing patterns among doctors treating Medicare patients. Report
> GlaxoSmithKline asked European regulators to approve a gene therapy to treat a rare immunodeficiency disease in children known as "bubble boy disease." Report
And Finally... The New York Times published an editorial backing Medicare negotiation powers on drug prices. Report (sub. req.)